Latest Technology News

AdAlta Limited has completed the final share issuance under its Investment Agreement with the Meurs Group, securing the full $700,000 investment that bolstered its cellular immunotherapy development.

xReality Group (XRG) has reported robust growth driven by its flagship Operator XR training system, securing a landmark $5.7 million contract with the Texas Department of Public Safety and unveiling ambitious plans for new product launches and global expansion.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

DUG Technology reports a robust start to FY26 with 19% revenue growth and a landmark SaaS and HPCaaS contract, marking key international milestones.

OD6 Metals has selected a cutting-edge rare earth processing flowsheet delivering ~75% recovery of key elements and completed metallurgical drilling at Splinter Rock, supported by a $2.5 million capital raise. The company also commenced Phase 2 drilling at its Gulf Creek Copper Project, maintaining a strong cash position.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Tarrina Resources is set to acquire promising exploration assets in NSW and SA, backed by a $5 million capital raise. The move aims to reposition the company within the mining sector and secure its ASX listing.

CONNEQT Health has landed a significant Phase 2b clinical trial contract in the US, advancing its footprint in cardiovascular disease research with proprietary vascular assessment technology.

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.

Heavy Rare Earths Limited has completed the acquisition of an 80% interest in the Prospect Hill Tin Project, South Australia’s most advanced tin asset, setting the stage for a swift maiden resource estimate.

Arovella Therapeutics has secured encouraging feedback from the US FDA on reagent testing for its CAR-iNKT cell therapy, setting the stage for an IND filing this quarter and clinical trials in early 2026.

NOVONIX has reached mutual agreement to draw down an additional US$40 million tranche of convertible debentures from Yorkville Advisors, advancing its funding strategy to support growth in battery technology.